Perou et al. initially defined four molecular subtypes based on transcriptomic profiles of 496 genes [6]: luminal-like, human epidermal growth factor receptor (or HER2)-positive (HER2-positive), basal-like breast cancer (BLBC), and normal-like. This evidence concerns the gene ERBB2 and breast cancer.